September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
A mouse model to study Aβ-driven pathology in the ageing retina.
Author Affiliations & Notes
  • Savannah Amy Lynn
    Clinical and Experimental Sciences, The University of Southampton, Southampton, United Kingdom
  • Srini Goverdhan
    Clinical and Experimental Sciences, The University of Southampton, Southampton, United Kingdom
  • Rosie Munday
    Clinical and Experimental Sciences, The University of Southampton, Southampton, United Kingdom
  • Jennifer Scott
    Clinical and Experimental Sciences, The University of Southampton, Southampton, United Kingdom
  • Thomas Freeman
    Clinical and Experimental Sciences, The University of Southampton, Southampton, United Kingdom
  • David Johnston
    Clinical and Experimental Sciences, The University of Southampton, Southampton, United Kingdom
  • Andrew J Lotery
    Clinical and Experimental Sciences, The University of Southampton, Southampton, United Kingdom
  • J Arjuna Ratnayaka
    Clinical and Experimental Sciences, The University of Southampton, Southampton, United Kingdom
  • Footnotes
    Commercial Relationships   Savannah Lynn, None; Srini Goverdhan, None; Rosie Munday, None; Jennifer Scott, None; Thomas Freeman, None; David Johnston, None; Andrew Lotery, None; J Arjuna Ratnayaka, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 6534. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Savannah Amy Lynn, Srini Goverdhan, Rosie Munday, Jennifer Scott, Thomas Freeman, David Johnston, Andrew J Lotery, J Arjuna Ratnayaka; A mouse model to study Aβ-driven pathology in the ageing retina.. Invest. Ophthalmol. Vis. Sci. 2016;57(12):6534.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The Alzheimer’s-linked Amyloid beta (Aβ) peptide is reported to be deposited in aged retinas. Aβ has been implicated in key stages of Age-related Macular Degeneration (AMD), yet its role remains poorly understood. Here we employ a mouse model to study the in-vivo effects of Aβ to delineate its mechanisms of action and to understand how Aβ triggers/drives retinal pathology with age.

Methods : Aβ was characterised by negative stain TEM and immunogold labelling. C57BL/6 mice were subretinally injected with 3µL of oligomeric Aβ1-42 (625nM, n=5) or vehicle control (n=3). At 8 days post-injection eyes were enucleated, OCT-embedded and cryosectioned at 16µM intervals for histological analysis. H&E staining and confocal immunofluorescence analysed retinal morphology in response to Aβ exposure and reported Aβ localisation. Exclusion criteria included a 200µM radius from the injection site to omit areas of mechanical trauma. Morphometric analysis was performed blind using OlyVIA and ImageJ. Data is expressed as means ± SEM with a statistical significance of *P ≤ 0.05.

Results : TEM and Dot Blot assay enabled us to identify a window in which Aβ is reported to be most toxic. Fundus images showed large areas of pathology in Aβ exposed mice (9582 ± 4831) compared to controls (48.33 ± 8.97) which were indistinguishable from non-injected littermates, p=0.12. Serial line scans of Aβ injected mice revealed a 2-fold increase in RPE hypopigmentation associated with photoreceptor outer segment (POS) loss, RPE disorganisation and RPE hypertrophy compared to controls. Similarly, confocal data showed POS and inner segment disorganisation compared to well-preserved retinal architecture in control retinas. Aβ was detected in multiple retinal locations including POS, the RPE/choroid interface and the outer and inner plexiform layers.

Conclusions : Our findings demonstrate that subretinal Aβ injections faithfully recapitulate key features of early AMD including dysfunctional RPE and damaged photoreceptors. Critically, we found no obvious indication of apoptosis or disruption of the blood-retinal barrier indicating gradual cellular impairment over time. Previously published literature showing static images of Abeta in human post-mortem eyes tantalisingly correlates the presence of Aβ with high drusen-loads and AMD. Our model therefore represents a powerful tool to investigate the dynamic nature of Aβ-mediated pathology in living retinas.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×